SCHEMBL19238241

SCHEMBL19238241

c1cc2c3c(ccc(-n4c5ccccc5c5cc(-n6c7ccccc7c7ccccc76)ccc54)c3c1)-c1ccncc1-2

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 3/20 0.33
▸ CYP17A1 P05093 2/20 0.33
▸ L3MBTL1 Q9Y468 2/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ ATM Q13315 1/20 0.33
▸ DUSP3 P51452 1/20 0.32
▸ MAOA P21397 5/20 0.31
▸ MAOB P27338 5/20 0.31
▸ ACHE P22303 1/20 0.31
▸ CRHBP P24387 1/20 0.31
▸ CRHR2 Q13324 1/20 0.31
▸ KEAP1 Q14145 1/20 0.31
▸ NFE2L2 Q16236 1/20 0.31
▸ TOP2A P11388 1/20 0.30
▸ METAP2 P50579 1/20 0.30
▸ ALDH1A1 P00352 1/20 0.30
▸ HPGD P15428 1/20 0.30
▸ TSHR P16473 1/20 0.30
▸ MAPK1 P28482 1/20 0.30
▸ CASP1 P29466 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19238254 1.00 CYP1A2 (0.33) CYP1A2CYP17A1L3MBTL1KDM4EATM
SCHEMBL19238251 0.89 KDM4E (0.38) CYP1A2CYP17A1L3MBTL1KDM4EATM
SCHEMBL19238242 0.89 KDM4E (0.38) CYP1A2CYP17A1L3MBTL1KDM4EATM
SCHEMBL19238240 0.88 CYP17A1 (0.34) CYP1A2CYP17A1L3MBTL1KDM4EATM
SCHEMBL19238256 0.88 CYP17A1 (0.34) CYP1A2CYP17A1L3MBTL1KDM4EATM
SCHEMBL19238290 0.87 L3MBTL1 (0.35) L3MBTL1KDM4EATMDUSP3ALDH1A1
SCHEMBL17952782 0.87 IDO1 (0.37) CYP1A2CYP17A1L3MBTL1KDM4EATM
SCHEMBL17952788 0.87 IDO1 (0.37) CYP1A2CYP17A1L3MBTL1KDM4EATM
SCHEMBL19238239 0.86 PIK3CA (0.36) CYP1A2CYP17A1L3MBTL1ATM
SCHEMBL19238253 0.86 PIK3CA (0.36) CYP1A2CYP17A1L3MBTL1ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10629821-B2 Compound, material for organic electroluminescent elements using same, and organic electroluminescent element and electronic device each using same IDEMITSU KOSAN CO., LTD. (JP) 2020-04-21 — — US disclosed
US-20170237016-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS USING SAME, AND ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE EACH USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2017-08-17 — — US disclosed
US-20170237016-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS USING SAME, AND ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE EACH USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2017-08-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170237016-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS USING SAME, AND ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE EACH USING SAME OR10J3, LEF1, PIEZO1 CYP1A2 2636/4885CYP17A1 3154/4885L3MBTL1 2776/4885
US-10629821-B2 Compound, material for organic electroluminescent elements using same, and organic electroluminescent element and electronic device each using same OR10J3, LEF1, PIEZO1 CYP1A2 2636/4885CYP17A1 3154/4885L3MBTL1 2776/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback